Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

July 22, 2027

Study Completion Date

July 22, 2027

Conditions
Dilated CardiomyopathyCardiovascular Diseases
Interventions
OTHER

Part 1: DCM Cohort

Patients with a confirmed diagnosis of DCM will have samples that undergo whole genome sequencing and biomarker analysis

OTHER

Part 2: Heritable CV Diseases and Family Members

Biomarker analysis will be undertaken on samples

Trial Locations (6)

LS1 3EX

RECRUITING

Leeds Teaching Hospitals NHS Trust, Leeds

LE3 9QP

RECRUITING

Glenfield Hospital, Leicester

L14 3PE

RECRUITING

Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool

SW3 6NP

RECRUITING

Royal Brompton & Harefield NHS Foundation Trust, London

Unknown

RECRUITING

Oxford University Hospitals NHS Foundation Trust, Oxford

SO16 6YD

NOT_YET_RECRUITING

Southampton General Hospital, Southampton

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER